The changing landscape of myeloma therapy.
Cavo
Michele
M
Baccarani
Michele
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008558:Melphalan / Q000008:administration & dosage; D009101:Multiple Myeloma / Q000401:mortality / Q000628:therapy*; D012008:Recurrence; D015996:Survival Rate; D013792:Thalidomide / Q000627:therapeutic use*
D013792:Thalidomide; D008558:Melphalan